Literature DB >> 1702841

Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1.

C Leclerc1, E Deriaud, V Mimic, S van der Werf.   

Abstract

Proliferative T-cell responses to poliovirus in various strains of mice have been analyzed by using either killed purified virus or capsid protein VP1 synthetic peptides. Following immunization of mice with inactivated poliovirus type 1 (PV1), a specific proliferative response of their lymph node CD4+ T cells was obtained after in vitro stimulation with purified virus. In mice immunized with PV1, PV2, or PV3, a strong cross-reactivity of the T-cell responses was observed after in vitro stimulation with heterologous viruses. By using various strategies, a dominant T-cell epitope was identified in the amino acid 103 to 115 region of capsid polypeptide VP1, close by the C3 neutralization epitope. The T-cell response to VP1 amino acids 103 to 115 is H-2 restricted: H-2d mice are responders, whereas H-2k and H-2b mice do not respond to this T-cell epitope. Immunization of BALB/c (H-2d) mice with the uncoupled p86-115 peptide, which represents VP1 amino acids 86 to 115 and contains both the T-cell epitope and the C3 neutralization epitope, induced poliovirus-specific B- and T-cell responses. Moreover, these mice developed poliovirus neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1702841      PMCID: PMC239810     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies.

Authors:  M Chow; R Yabrov; J Bittle; J Hogle; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

2.  Three-dimensional structure of poliovirus at 2.9 A resolution.

Authors:  J M Hogle; M Chow; D J Filman
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

3.  Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope.

Authors:  D R Milich; J L Hughes; A McLachlan; G B Thornton; A Moriarty
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

4.  Expression of a poliovirus neutralization epitope at the surface of recombinant bacteria: first immunization results.

Authors:  A Charbit; S Van der Werf; V Mimic; J C Boulain; M Girard; M Hofnung
Journal:  Ann Inst Pasteur Microbiol       Date:  1988 Jan-Feb

5.  Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes.

Authors:  T J Palker; T J Matthews; A Langlois; M E Tanner; M E Martin; R M Scearce; J E Kim; J A Berzofsky; D P Bolognesi; B F Haynes
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

6.  Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

Authors:  D P Dialynas; Z S Quan; K A Wall; A Pierres; J Quintáns; M R Loken; M Pierres; F W Fitch
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

7.  Immune response to uncoupled peptides of foot-and-mouth disease virus.

Authors:  M J Francis; C M Fry; D J Rowlands; J L Bittle; R A Houghten; R A Lerner; F Brown
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

8.  Murine cell-mediated immune response recognizes an enterovirus group-specific antigen(s).

Authors:  M A Beck; S M Tracy
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

9.  Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I.

Authors:  M G Murray; J Bradley; X F Yang; E Wimmer; E G Moss; V R Racaniello
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

10.  Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice.

Authors:  A Martin; C Wychowski; T Couderc; R Crainic; J Hogle; M Girard
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

View more
  24 in total

1.  Carbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines.

Authors:  Qian Qin; Zhaojun Yin; Philip Bentley; Xuefei Huang
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

2.  Impaired gamma interferon responses against parvovirus B19 by recently infected children.

Authors:  A Corcoran; S Doyle; D Waldron; A Nicholson; B P Mahon
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio.

Authors:  Rahnuma Wahid; Martin J Cannon; Marie Chow
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Robust immune responses elicited by a fully synthetic three-component vaccine.

Authors:  Sampat Ingale; Margreet A Wolfert; Jidnyasa Gaekwad; Therese Buskas; Geert-Jan Boons
Journal:  Nat Chem Biol       Date:  2007-09-02       Impact factor: 15.040

5.  Identification of a major T-cell epitope within VP3 amino acid residues 24 to 37 of Theiler's virus in demyelination-susceptible SJL/J mice.

Authors:  R L Yauch; K Kerekes; K Saujani; B S Kim
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors.

Authors:  Sampat Ingale; Margreet A Wolfert; Therese Buskas; Geert-Jan Boons
Journal:  Chembiochem       Date:  2009-02-13       Impact factor: 3.164

7.  Poliovirus-specific major histocompatibility complex class I-restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regions.

Authors:  M Kutubuddin; J Simons; M Chow
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

8.  Identification of T-helper epitopes in the VP1 capsid protein of poliovirus.

Authors:  M Kutubuddin; J Simons; M Chow
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

9.  Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1.

Authors:  J F Dedieu; J Ronco; S van der Werf; J M Hogle; Y Henin; M Girard
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

10.  Cloning and expression of the gene for the Avi-3 antigen of Mycobacterium avium and mapping of its epitopes.

Authors:  R Yamaguchi; K Matsuo; A Yamazaki; M Takahashi; Y Fukasawa; M Wada; C Abe
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.